These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1736770)

  • 1. Efficacy and risks of moricizine in inducible sustained ventricular tachycardia.
    Damle R; Levine J; Matos J; Greenberg S; Brooks R; Frumkin W; Goldberger J; Kadish AH
    Ann Intern Med; 1992 Mar; 116(5):375-81. PubMed ID: 1736770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiologic response to moricizine in patients with sustained ventricular arrhythmias.
    Powell AC; Gold MR; Brooks R; Garan H; Ruskin JN; McGovern BA
    Ann Intern Med; 1992 Mar; 116(5):382-7. PubMed ID: 1736771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological evaluation of moricizine in patients with sustained ventricular tachyarrhythmias: low efficacy and high incidence of proarrhythmia.
    Bhandari AK; Lerman R; Ehrlich S; Sager P; Leon C; Widerhorn J; Cannom DS
    Pacing Clin Electrophysiol; 1993 Sep; 16(9):1853-61. PubMed ID: 7692418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of proarrhythmic events during moricizine therapy and their relationship to ventricular function.
    Tschaidse O; Graboys TB; Lown B; Lampert S; Ravid S
    Am Heart J; 1992 Oct; 124(4):912-6. PubMed ID: 1529903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of moricizine in malignant ventricular arrhythmias.
    Horowitz LN
    Am J Cardiol; 1990 Feb; 65(8):41D-46D; discussion 68D-71D. PubMed ID: 1689535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethmozine (moricizine HCl) therapy for complex ventricular arrhythmias.
    Hession MJ; Lampert S; Podrid PJ; Lown B
    Am J Cardiol; 1987 Oct; 60(11):59F-66F. PubMed ID: 3310587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiology of Ethmozine (moricizine HCl) for ventricular tachycardia.
    Wyndham CR; Pratt CM; Mann DE; Winkle RA; Somberg J; de Maria AN; Josephson ME
    Am J Cardiol; 1987 Oct; 60(11):67F-72F. PubMed ID: 3310588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethmozine: electrophysiology, hemodynamics, and antiarrhythmic efficacy in patients with life-threatening ventricular arrhythmias.
    Dorian P; Echt DS; Mead RH; Lee JT; Lebsack CS; Winkle RA
    Am Heart J; 1986 Aug; 112(2):327-33. PubMed ID: 3526852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moricizine: a new class I antiarrhythmic.
    Mann HJ
    Clin Pharm; 1990 Nov; 9(11):842-52. PubMed ID: 2272151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moricizine-induced proarrhythmia.
    Seaborg SM; Cowan MD
    Clin Cardiol; 1992 Nov; 15(11):866-7. PubMed ID: 10969633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moricizine. A review of its pharmacological properties, and therapeutic efficacy in cardiac arrhythmias.
    Fitton A; Buckley MT
    Drugs; 1990 Jul; 40(1):138-67. PubMed ID: 2202581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic efficacy of ethmozine in patients with ventricular tachycardia as determined by programmed electrical stimulation.
    Miura DS; Wynn J; Torres V; Laux B; Keefe D; Somberg JC
    Am Heart J; 1986 Apr; 111(4):661-6. PubMed ID: 3513503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moricizine: pharmacodynamic, pharmacokinetic, and therapeutic profile of a new antiarrhythmic.
    Vanerio G; Maloney JD
    Cleve Clin J Med; 1992; 59(1):79-86. PubMed ID: 1551218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inefficacy and proarrhythmic effects of flecainide and encainide for sustained ventricular tachycardia and ventricular fibrillation.
    Herre JM; Titus C; Oeff M; Eldar M; Franz MR; Griffin JC; Scheinman MM
    Ann Intern Med; 1990 Nov; 113(9):671-6. PubMed ID: 2121082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moricizine: a novel antiarrhythmic agent.
    Carnes CA; Coyle JD
    DICP; 1990; 24(7-8):745-53. PubMed ID: 2197817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natural history of benign and potentially malignant ventricular arrhythmias with special reference to nonsustained ventricular tachycardia.
    Pratt CM; Francis M; Mahler S; Aogaichi K; Keus P; Young JB
    Am Heart J; 1988 Oct; 116(4):897-903. PubMed ID: 2459950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proarrhythmic potential of moricizine: strengths and limitations of a data base analysis.
    Pratt CM
    Am J Cardiol; 1990 Feb; 65(8):51D-55D; discussion 68D-71D. PubMed ID: 1689536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and characteristics of proarrhythmia from moricizine (Ethmozine).
    Morganroth J; Pratt CM
    Am J Cardiol; 1989 Jan; 63(3):172-6. PubMed ID: 2642632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise induced fatal sinusoidal ventricular tachycardia secondary to moricizine.
    Nazari J; Bauman J; Pham T; Ivanovich L; Kehoe RF
    Pacing Clin Electrophysiol; 1992 Oct; 15(10 Pt 1):1421-4. PubMed ID: 1383951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moricizine hydrochloride (Ethmozine).
    Dunn SL
    Crit Care Nurse; 1992 Apr; 12(4):61-3. PubMed ID: 1568380
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.